Usefulness of neutrophil/lymphocyte ratio in predicting early recurrence after radiofrequency catheter ablation in patients with atrial fibrillation

International Journal of Cardiology

Volumn 168, Issue 4, 2013, Pages 4398-4400

  Im, Sung Il ^a   Shin, Seung Yong ^b   Na, Jin Oh ^a   Kim, Yong Hyun ^c   Choi, Cheol Ung ^a   Kim, Seong Hwan ^c   Kim, Jin Won ^a   Kim, Eung Ju ^a   Han, Seong Woo ^d   Rha, Seung Woon ^a   Park, Chang Gyu ^a   Seo, Hong Seog ^a   Oh, Dong Joo ^a   Hwang, Chun ^e   Lim, Hong Euy ^a  

^a Korea University College of Medicine   (South Korea)

^b Chung Ang University College of Medicine   (South Korea)

^c Korea University College of Medicine   (South Korea)

^d Hallym University   (South Korea)

^e UTAH VALLEY REGIONAL MEDICAL CENTER   (United States)

Author keywords

Ablation time; Atrial fibrillation; Catheter ablation; Myocardial injury; Neutrophil lymphocyte ratio

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATINE KINASE MB; TROPONIN T;

ADULT; CATHETER ABLATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART MUSCLE INJURY; HUMAN; LETTER; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; NEUTROPHIL LYMPHOCYTE RATIO; PREDICTIVE VALUE; PRIORITY JOURNAL; RECURRENCE RISK; ATRIAL FIBRILLATION; BLOOD; LEUKOCYTE COUNT; LYMPHOCYTE; MIDDLE AGED; NEUTROPHIL; RECURRENT DISEASE; TIME;

ATRIAL FIBRILLATION; CATHETER ABLATION; FEMALE; HUMANS; LEUKOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; PREDICTIVE VALUE OF TESTS; RECURRENCE; TIME FACTORS;

EID: 84886303079     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.05.042     Document Type: Article

References (9)

1. R. Cappato, H. Calkins, S.A. Chen, W. Davies, Y. Iesaka, and J. Kalman Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation Circ Arrhythm Electrophysiol 3 2010 32 38
2. H. Calkins, K.H. Kuck, R. Cappato, J. Brugada, A.J. Camm, and S.A. Chen 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society Heart Rhythm 9 2012 632 696 e21
3. L. Cai, Y. Yin, Z. Ling, L. Su, Z. Liu, and J. Wu Predictors of late recurrence of atrial fibrillation after catheter ablation Int J Cardiol 164 2013 82 87
4. B. Belhassen Corticosteroid therapy after catheter ablation of atrial fibrillation for an authentic "blanking period" J Am Coll Cardiol 56 2010 1473 1475
5. H.E. Lim, C.U. Choi, J.O. Na, J.I. Choi, S.H. Kim, and J.W. Kim Effects of iatrogenic myocardial injury on coronary microvascular function in patients undergoing radiofrequency catheter ablation of atrial fibrillation Circ Arrhythm Electrophysiol 6 2013 318 326
6. C.P. de Jager, P.T. van Wijk, R.B. Mathoera, J. de Jongh-Leuvenink, T. van der Poll, and P.C. Wever Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit Crit Care 14 2010 R192
7. T. Rostock, D. Steven, B. Lutomsky, H. Servatius, I. Drewitz, and H. Klemm Atrial fibrillation begets atrial fibrillation in the pulmonary veins on the impact of atrial fibrillation on the electrophysiological properties of the pulmonary veins in humans J Am Coll Cardiol 51 2008 2153 2160
8. Y. Nakazawa, T. Ashihara, T. Tsutamoto, M. Ito, and M. Horie Endothelin-1 as a predictor of atrial fibrillation recurrence after pulmonary vein isolation Heart Rhythm 6 2009 725 730
9. A.A. Hussein, W.I. Saliba, D.O. Martin, M. Shadman, M. Kanj, and M. Bhargava Plasma B-type natriuretic peptide levels and recurrent arrhythmia after successful ablation of lone atrial fibrillation Circulation 123 2011 2077 2082